Positionen, Richtlinien & Downloads
| Date | Title | Type | Download |
|---|---|---|---|
| 2021/07 | Energy Conservation | Position | (128 KB) |
| 2021/07 | Nanotechnology | Position | (87 KB) |
| 2021/07 | Prevention of Misuse of Biological Materials and Toxins for Biowarfare | Position | (106 KB) |
| 2021/07 | Water | Position | (100 KB) |
| 2021/07 | Halbjahresbericht 2021 | Brochure | (1 MB) |
| 2021/06 | EFPIA Disclosure Code Self-Certification Scheme | Policy | (395 KB) |
| 2021/06 | Roche Position on TRIPS and the Doha Declaration | Position | (17 KB) |
| 2021/06 | Roche Position on Enabling Access through Collaboration | Position | (526 KB) |
| 2018/08 | Climate Change Risk Management | Fact Sheet | (153 KB) |
| 2016/08 | Policy on Safety, Security, Health and Environmental Protection | Policy | (188 KB) |
| 2021/05 | Roche’s Approach to Tax – General Description and Principles | Principles | (282 KB) |
| 2021/05 | Roche's Position on Partnering with Patient Communities | Position | (32 KB) |
| 2021/02 | Finanzbericht 2020 | Brochure | (4 MB) |
| 2021/02 | Geschäftsbericht 2020 | Brochure | (7 MB) |
| 2021/02 | Roche Position on Health Technology Assessment | Position | (73 KB) |
| 2020/07 | Halbjahresbericht 2020 | Brochure | (2 MB) |
| 2020/06 | EFPIA Disclosure Code Self-Certification Scheme | Policy | (143 KB) |
| 2016/10 | Biodiversity | Position | (219 KB) |
| 2020/04 | Biotechnology - Safety Health and Environmental Aspects | Position | (338 KB) |
| 2020/04 | Clinical Research | Position | (446 KB) |
| 2016/10 | Counterfeiting | Position | (443 KB) |
| 2020/04 | Greenhouse gases / Climate Change | Position | (374 KB) |
| 2020/04 | Position on Human Specimen Resources (Biobanks) | Position | (225 KB) |
| 2020/04 | Human Stem Cells | Position | (467 KB) |
| 2020/04 | Landfills / Contaminated Soil | Position | (304 KB) |
| 2020/04 | Personalised Healthcare | Position | (250 KB) |
| 2020/04 | Pharmaceuticals in the Environment | Position | (378 KB) |
| 2020/04 | Pricing | Position | (412 KB) |
| 2020/04 | R&D for Neglected Tropical Disease | Position | (253 KB) |
| 2020/04 | Similar Biotherapeutic Products - Biosimilars | Position | (302 KB) |
| 2020/04 | Pollution Prevention and Reduction | Position | (461 KB) |
| 2020/04 | Waste Management | Position | (297 KB) |
| 2020/04 | Product Stewardship | Position | (591 KB) |
| 2020/04 | Pre-Approval Access to Investigational Medicinal Products | Position | (488 KB) |
| 2020/04 | Safety, Security, Health and Environmental Protection (SHE) in the supply chain | Position | (490 KB) |
| 2020/04 | Human Rights | Position | (360 KB) |
| 2020/04 | Human Genetic and Genomic Research | Position | (433 KB) |
| 2020/04 | Roche’s Position on Access to & Use of Real World Data | Position | (425 KB) |
| 2020/04 | Animal Research at Roche | Position | (413 KB) |
| 2020/02 | Verhaltenskodex der Roche-Gruppe (Chinesisch) | Policy | (3 MB) |
| 2020/02 | Verhaltenskodex der Roche-Gruppe (Deutsch) | Policy | (3 MB) |
| 2020/02 | Roche Group Code of Conduct (Spanish) | Policy | (3 MB) |
| 2020/02 | Verhaltenskodex der Roche-Gruppe (Französisch) | Policy | (3 MB) |
| 2020/02 | Verhaltenskodex der Roche-Gruppe - Nachtrag für Frankreich (Französisch) | Policy | (14 MB) |
| 2020/02 | Verhaltenskodex der Roche-Gruppe (Italienisch) | Policy | (3 MB) |
| 2020/02 | Verhaltenskodex der Roche-Gruppe (Portugiesisch - Brasilien) | Policy | (3 MB) |
| 2020/02 | Verhaltenskodex der Roche-Gruppe (Japanisch) | Policy | (3 MB) |
| 2020/02 | Verhaltenskodex der Roche-Gruppe (Portugiesisch) | Policy | (3 MB) |
| 2020/02 | Verhaltenskodex der Roche-Gruppe (Russisch) | Policy | (3 MB) |
| 2020/02 | Verhaltenskodex der Roche-Gruppe (Türkisch) | Policy | (3 MB) |
| 2020/02 | Verhaltenskodex der Roche-Gruppe (Englisch) | Policy | (3 MB) |
| 2020/01 | Roche in Kürze 2019 | Brochure | (1 MB) |
| 2020/01 | Finanzbericht 2019 | Brochure | (4 MB) |
| 2020/01 | Geschäftsbericht 2019 | Brochure | (7 MB) |
| 2019/12 | Supplier Code of Conduct (French) | Guidelines | (1 MB) |
| 2016/08 | Supplier Code of Conduct (English) | Guidelines | (810 KB) |
| 2019/07 | Halbjahresbericht 2019 | Brochure | (4 MB) |
| 2019/07 | EFPIA Disclosure Code Self-Certification Scheme | Policy | (175 KB) |
| 2019/02 | SHE Guidelines | Guidelines | (1 MB) |
| 2019/01 | Roche in Kürze 2018 | Brochure | (2 MB) |
| 2019/01 | Finanzbericht 2018 | Brochure | (2 MB) |
| 2019/01 | Geschäftsbericht 2018 | Brochure | (8 MB) |
| 2019/01 | Einhaltung von Gesetzen | Fact Sheet | (154 KB) |
| 2019/01 | Roche-Berufskrankheitsrate (RIR) und Berufskrankheiten | Fact Sheet | (244 KB) |
| 2019/01 | Roche-Unfallrate (RAR) | Fact Sheet | (446 KB) |
| 2019/01 | Förderung der Biodiversität | Fact Sheet | (151 KB) |
| 2019/01 | Abfallmanagement | Fact Sheet | (394 KB) |
| 2019/01 | Wasserverbrauch | Fact Sheet | (211 KB) |
| 2019/01 | Emissions to water | Fact Sheet | (199 KB) |
| 2019/01 | Andere Emissionen in die Luft | Fact Sheet | (195 KB) |
| 2019/01 | Treibhausgasemissionen | Fact Sheet | (316 KB) |
| 2019/01 | Energieverbrauch | Fact Sheet | (214 KB) |
| 2019/01 | Ökobilanz | Fact Sheet | (297 KB) |
| 2019/01 | SGU-Ausgaben | Fact Sheet | (178 KB) |
| 2019/01 | Wesentliche Themen | Fact Sheet | (200 KB) |
| 2018/12 | Roche Directive Collaborating with Patient Groups and Patients | Guidelines | (252 KB) |
| 2018/10 | Intellectual Property, Fueling Innovation & Advancing Healthcare | Position | (287 KB) |
| 2018/10 | Certificate on Roche's Sustainability Commitments, Initiatives and Performance | Fact Sheet | (247 KB) |
| 2018/09 | Leitfaden zur Personalpolitik der Roche-Gruppe | Policy | (390 KB) |
| 2018/07 | Halbjahresbericht 2018 | Brochure | (2 MB) |
| 2018/06 | Group Business Continuity Management Policy | Policy | (362 KB) |
| 2018/05 | Working with Government Officials | Guidelines | (65 KB) |
| 2013/05 | Spenden und nichtkommerzielles Sponsoring | Policy | (190 KB) |
| 2018/03 | Organisationsreglement | Policy | (189 KB) |
| 2018/03 | Bylaws | Policy | (267 KB) |
| 2018/02 | Transporte | Fact Sheet | (177 KB) |
| 2018/02 | Roche in Kürze 2017 | Brochure | (989 KB) |
| 2018/02 | Finanzbericht 2017 | Brochure | (2 MB) |
| 2018/02 | Geschäftsbericht 2017 | Brochure | (4 MB) |
| 2017/11 | Roche Policy on sharing of clinical study information | Policy | (66 KB) |
| 2017/06 | EFPIA Disclosure Code Self-Certification Scheme | Policy | (53 KB) |
| 2017/05 | Benefits - Switzerland | Brochure | (27 MB) |
| 2017/02 | Full Year 2016 Presentation without appendix | Brochure | (2 MB) |
| 2017/01 | Finanzbericht 2016 | Brochure | (2 MB) |
| 2016/06 | Counterfeit Medicinal products | FAQs | (365 KB) |
| 2016/03 | SHE Organization Chart | Fact Sheet | (47 KB) |
| 2016/03 | Verhalten im Wettbewerb | Guidelines | (184 KB) |
| 2016/03 | Statuten | Policy | (504 KB) |
| 2015/09 | Group Insider Policy | Policy | (198 KB) |
| 2015/05 | Roche Specimen Repositories | FAQs | (219 KB) |
| 2015/02 | Directive K18 - Annex 2 (Lighting) | Brochure | (53 KB) |
| 2014/10 | Directive K1 - Annex 5 (Mental Health Protection) | Policy | (1 MB) |
| 2014/10 | Directive K1 - Occupational Health | Policy | (44 KB) |
| 2014/04 | Verhalten im Geschäftsverkehr | Guidelines | (152 KB) |
| 2014/04 | Behaviour in Business (German) | Guidelines | (126 KB) |
| 2014/04 | Behaviour in Business (French) | Guidelines | (149 KB) |
| 2014/03 | PROTOKOLL der 96. ordentlichen Generalversammlung der Aktionare der ROCHE HOLDING AG | Fact Sheet | (8 MB) |
| 2013/10 | Continued Access to Investigational Medicines | Policy | (295 KB) |
| 2012/03 | Risk Management | Policy | (88 KB) |
| 2009/10 | Memberships and International CR Recommendations | Fact Sheet | (62 KB) |
No results found.